Top Markets
Coin of the day
9 Meters Biopharma, Inc. 9 Meters Biopharma, Inc.

9 Meters Biopharma, Inc.

NMTR
Ранг среди акций #40890
Based in Raleigh, North Carolina, 9 Meters Biopharma, Inc. operates as a... Based in Raleigh, North Carolina, 9 Meters Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. Its core mission is to innovate treatments for individuals suffering from rare digestive conditions, gastrointestinal disorders with inadequate therapeutic options, and other severe debilitating ailments. The company's pipeline features several promising drug candidates. Larazotide, an 8-amino acid peptide, is currently in a Phase 3 clinical trial for the treatment of celiac disease and is also being assessed in a Phase IIa study for multi-system inflammatory syndrome. Another key asset, Vurolenatide, a long-acting injectable glucagon-like peptide-1, is undergoing Phase 2 clinical trials to address short bowel syndrome. Additionally, 9 Meters Biopharma is advancing other compounds, including NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist intended for the prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody designed to target specific obesity disorders; and NM-004, a double-cleaved mesalamine combined with an immunomodulator, slated for rare and/or orphan indications.
Цена акции
$0.0169
Последняя синхронизация: 2023-08-21
Рыночная капитализация
$66.40K
Изменение (1 день)
4.32%
Изменение (1 год)
0.00%
Страна
US
Торговля 9 Meters Biopharma, Inc. (NMTR)

Категория

История цены акций 9 Meters Biopharma, Inc. (NMTR)
Наивысшая цена закрытия: $0.02 2023-08-01

Наименьшая цена закрытия: $686.06 2016-07-01
История цены акций 9 Meters Biopharma, Inc. с 2016 по 2026
Годовая динамика цены акций
Год Результативность
2023 -98.82%
2022 -92.87%
2021 7.49%
2020 28.30%
2019 -72.54%
2018 -60.37%
2017 -60.70%
2016 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$524.45 32.46%
US
$863.27 33.51%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE